These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

127 related items for PubMed ID: 25200689

  • 41. Altered methylation and expression patterns of genes regulating placental angiogenesis in preterm pregnancy.
    Sundrani DP, Reddy US, Chavan-Gautam PM, Mehendale SS, Chandak GR, Joshi SR.
    Reprod Sci; 2014 Dec; 21(12):1508-17. PubMed ID: 24803508
    [Abstract] [Full Text] [Related]

  • 42. Placental growth factor and soluble FMS-like tyrosine kinase-1 in early-onset and late-onset preeclampsia.
    Wikström AK, Larsson A, Eriksson UJ, Nash P, Nordén-Lindeberg S, Olovsson M.
    Obstet Gynecol; 2007 Jun; 109(6):1368-74. PubMed ID: 17540809
    [Abstract] [Full Text] [Related]

  • 43. Evidence supporting a role for blockade of the vascular endothelial growth factor system in the pathophysiology of preeclampsia. Young Investigator Award.
    Chaiworapongsa T, Romero R, Espinoza J, Bujold E, Mee Kim Y, Gonçalves LF, Gomez R, Edwin S.
    Am J Obstet Gynecol; 2004 Jun; 190(6):1541-7; discussion 1547-50. PubMed ID: 15284729
    [Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45. Angiogenic and inflammatory biomarkers for screening and follow-up in patients with pulmonary arterial hypertension.
    Kylhammar D, Hesselstrand R, Nielsen S, Scheele C, Rådegran G.
    Scand J Rheumatol; 2018 Jul; 47(4):319-324. PubMed ID: 29528272
    [Abstract] [Full Text] [Related]

  • 46. Gestational angiogenic biomarker patterns in high risk preeclampsia groups.
    Maynard SE, Crawford SL, Bathgate S, Yan J, Robidoux L, Moore M, Moore Simas TA.
    Am J Obstet Gynecol; 2013 Jul; 209(1):53.e1-9. PubMed ID: 23517919
    [Abstract] [Full Text] [Related]

  • 47. Selected angiogenic factors in plasma of patients with lower limb symptomatic peripheral arterial disease: preliminary report.
    Wieczór R, Gadomska G, Góralczyk B, Stankowska K, Budzyński J, Fabisiak J, Suppan K, Pulkowski G, Rość D.
    Int Angiol; 2015 Dec; 34(6):545-51. PubMed ID: 25394959
    [Abstract] [Full Text] [Related]

  • 48. Maternal serum sFlt-1/PlGF ratio in twin pregnancies with and without pre-eclampsia in comparison with singleton pregnancies.
    Dröge L, Herraìz I, Zeisler H, Schlembach D, Stepan H, Küssel L, Henrich W, Galindo A, Verlohren S.
    Ultrasound Obstet Gynecol; 2015 Mar; 45(3):286-93. PubMed ID: 25491901
    [Abstract] [Full Text] [Related]

  • 49. Soluble vascular endothelial growth factor receptor-1 is reduced in patients with resistant hypertension after renal denervation.
    Eikelis N, Hering D, Marusic P, Walton AS, Lambert EA, Sata Y, Krum H, Lambert GW, Esler MD, Schlaich MP.
    J Hum Hypertens; 2017 Apr; 31(4):248-252. PubMed ID: 27604660
    [Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51. [Maternal serum concentration of placental growth factor (PIGF) and endothelial growth factor (VEGF) in pregnancies complicated by preeclampsia].
    Semczuk-Sikora A, Krzyzanowski A, Kwiatek M, Semczuk M.
    Ginekol Pol; 2007 Nov; 78(11):873-6. PubMed ID: 18306920
    [Abstract] [Full Text] [Related]

  • 52. Progesterone - induced blocking factor (PIBF) and Th(1)/Th(2) cytokine in women with threatened spontaneous abortion.
    Hudić I, Fatusić Z.
    J Perinat Med; 2009 Nov; 37(4):338-42. PubMed ID: 19290853
    [Abstract] [Full Text] [Related]

  • 53. Placental growth factor (PlGF) is a surrogate marker in preeclamptic hypertension.
    Teixeira PG, Cabral AC, Andrade SP, Reis ZS, da Cruz LP, Pereira JB, Martins BO, Rezende CA.
    Hypertens Pregnancy; 2008 Nov; 27(1):65-73. PubMed ID: 18293205
    [Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56. The vascular endothelial growth factor family in adverse pregnancy outcomes.
    Andraweera PH, Dekker GA, Roberts CT.
    Hum Reprod Update; 2012 Jul; 18(4):436-57. PubMed ID: 22495259
    [Abstract] [Full Text] [Related]

  • 57. Antiangiogenic effect of soluble vascular endothelial growth factor receptor-1 in placental angiogenesis.
    Ahmad S, Ahmed A.
    Endothelium; 2005 Jul; 12(1-2):89-95. PubMed ID: 16036320
    [Abstract] [Full Text] [Related]

  • 58. Soluble fms-like tyrosine kinase-1 and soluble endoglin in HIV-associated preeclampsia.
    Govender N, Naicker T, Rajakumar A, Moodley J.
    Eur J Obstet Gynecol Reprod Biol; 2013 Sep; 170(1):100-5. PubMed ID: 23806447
    [Abstract] [Full Text] [Related]

  • 59. Soluble endoglin and other circulating antiangiogenic factors in preeclampsia.
    Levine RJ, Lam C, Qian C, Yu KF, Maynard SE, Sachs BP, Sibai BM, Epstein FH, Romero R, Thadhani R, Karumanchi SA, CPEP Study Group.
    N Engl J Med; 2006 Sep 07; 355(10):992-1005. PubMed ID: 16957146
    [Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.